METHODS OF INCREASING THE CYTOTOXICITY OF CHEMOTHERAPEUTIC AGENTS WITH MULTISUBSTRATE INHIBITORS OF HISTONE, PROTEIN-LYS, POLYAMINE ACETYLATION, AND POLYAMINE METABOLISM
申请人:Vanderbilt University
公开号:US20160243063A1
公开(公告)日:2016-08-25
A method of treating cancer in a subject in need thereof, comprising administering to the subject a first amount of a compound of the HAT inhibitor of the following formula:
wherein R is chosen from coenzyme A, (CH
2
)
2
NHCO(CH
2
)
2
NHCOR
2
; (CH
2
)
2
NHCOR
3
; (CH
2
)
2
NHCO(CH
2
)
2
NHCOR
4
; R
1
is H, NH
2
, NH, N, and R
1
can optionally cyclize with at least one other X
2
to form a C
3-8
membered ring containing C, O, S, or N; R
2
is chosen from alkyl, cycloalkyl, aryl, heteroaryl; R
3
is chosen from an alkyl, cycloalkyl, aryl, heteroaryl; R
4
is chosen from CH(OH)C(CH
3
)
2
CH
2
)OCOR
2
; X
1
is chosen from H or can cyclize with one other X
2
or R
1
to form a C
3-8
membered ring containing C, O, S, or N; and X
2
is chosen from C, N, NH, and can optionally cyclize with at least one other X
2
or R
1
to form a C
3-8
membered ring containing C, O, S, or N; or a pharmaceutically acceptable salt or hydrate thereof, thereby treating the cancer.
一种治疗需要的患者体内癌症的方法,包括向患者投予以下式的HAT抑制剂化合物的第一量:其中R从辅酶A、(CH2)2NHCO(CH2)2NHCOR2;(CH2)2NHCOR3;(CH2)2NHCO(CH2)2NHCOR4中选择;R1为H、NH2、NH、N,且R1可以选择与至少另一个X2环化以形成含有C、O、S或N的C3-8环的环;R2从烷基、环烷基、芳基、杂环烷基中选择;R3从烷基、环烷基、芳基、杂环烷基中选择;R4从CH(OH)C(CH3)2CH2)OCOR2中选择;X1从H中选择,或者可以与另一个X2或R1环化以形成含有C、O、S或N的C3-8环;X2从C、N、NH中选择,或者可以选择与至少另一个X2或R1环化以形成含有C、O、S或N的C3-8环;或其药用盐或水合物,从而治疗癌症。